Colin W. O'Brien, MD; Stephen P. Juraschek, MD, PhD; Christina C. Wee, MD, MPH
Note: The institutional review board at Beth Israel Deaconess Medical Center deemed this study not to be human subjects research.
Acknowledgment: The authors thank Aaron Fleishman, MPH, for checking the statistical programs and outputs and the participants of NHIS for their important contributions.
Grant Support: Dr. Juraschek is supported by grant K23HL135273 from the National Heart, Lung, and Blood Institute of the National Institutes of Health.
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-0953.
Reproducible Research Statement: Study protocol and data set: Publicly available at www.cdc.gov/nchs/nhis/index.htm. Statistical code: Available from Dr. Wee (e-mail, email@example.com).
O'Brien CW, Juraschek SP, Wee CC. Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease in the United States: Results From the 2017 National Health Interview Survey. Ann Intern Med. 2019;171:596–598. [Epub ahead of print 23 July 2019]. doi: https://doi.org/10.7326/M19-0953
Download citation file:
Published: Ann Intern Med. 2019;171(8):596-598.
Published at www.annals.org on 23 July 2019
Cardiology, Coronary Risk Factors, Prevention/Screening.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use